Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein
Human Growth Hormone EIA Endocrine Function 025-BC-1033
...e enzyme immunoassay. It is based on the direct s...es are directed against separate antigenic determi...ation, insulin in the sample reacts with peroxidas...lin antibodies bound to the microplate wells. A s...
Medicine Products:(Date:8/8/2008)...ean of the Harvard School of Public Health, today ... Iranian authorities of Dr. Kamiar Alaei, a 2007 M...is brother, Dr. Arash Alaei. The brothers are Iran...ment of HIV/AIDS, an important public health probl... their welfare, as their whereabouts are unknown, ...
(Date:8/7/2008)...hildren,s Hospital & Research Center Oakland conti...ith the creation of a new medical journal focused ...H, Medical Director of Children,s Pediatric Rehabi...chief of the Journal of Pediatric Rehabilitation ...terly journal released its second issue in July 20...
(Date:8/7/2008)...IDs, lacked basic ethical standards, study finds ,...Blogs written by medical professionals may pose a ...the blogs may inadvertently reveal patient informa...e the issue. , The researchers analyzed the con...cent contained enough information to reveal the au...
(Date:8/7/2008)...es in consumer decision-making and,consumer health...ctrum, WASHINGTON, Aug. 7 /PRNewswire-USNewswire/...tion,s foremost thought leaders in health care,man...ices in Health Care,Consumer Empowerment and Prote...innovative and proven programs from health informa...
Breaking Medicine News(10 mins):Health News:Children's Hospital Oakland publishes first of its kind pediatric rehabilitation journal 2Health News:Medical Blogs May Threaten Patient Privacy 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 3...ctors, all newborns should be vaccinated against ... against possible disease from infected mothers.Pr...ommended only for newborns// whose mothers were kn...known.The new recommendation is listed in the chil...
...e FDA issued a statement about the potential for d...g, Accutane. And now, reports say that the 15-year... was prescribed the drug. At this point, investiga... J. Bishop, was actually taking Accutane at the ti...
...consumption of alcohol, which has already been sho...also ward off Alzheimer's disease and other types ...t seem to matter what people drink - the effect is...cohol consumption between one and three drinks a d...
... sleuths found that the absence of a certain prote...its water levels.Reported in the New England journ...idney works.// The protein aquaporin-1has a def...g of the kidneys",says Landon King,lead author of ...
Other Medicine News:Health News:Babies Need Vaccination 2(Date:8/6/2008)...Demonstrated the Safety and Efficacy of the ORMD 0...le, JERUSALEM, Israel, August 6 /PRNewswire-First...)( http://www.oramed.com ), a developer of,oral de... from the clinical,trial of its oral insulin capsu...duct had a good safety profile and was well tolera...
(Date:8/6/2008)..., Mich., Aug. 6 /- Terumo Heart, Inc....Heart(TM) Left Ventricular Assist,System (LVAS) to...Cardiovascular Center in Ann Arbor, Michigan. The ...D. National Co-Principal Investigator for the,Dura... first third,generation left ventricular assist sy...
(Date:8/5/2008)...nference Call to be held on Wednesday, August 6, 2... EXTON, Pa., Aug. 5 /- Iso...ve top-line efficacy and safety results from two,p...05 and IT-R-006) of the,Isolagen Therapy(TM) for t...h study, conducted under an FDA Special Protocol A...
(Date:8/5/2008)...d Women and Non-Whites New to Antiretroviral Thera...nd Whites, MEXICO CITY, Aug. 5 /PRNewswire-FirstC...-daily or twice-daily dosing of Abbott,s (NYSE:,AB...vir) tablet provided,similar results for controlli...proving the immune system (increasing CD4 cells) i...
Breaking Medicine Technology:Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule 2First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8American Medical Association Clears Path for Adenoviral Conjunctivitis Pink Eye Detector 5791 1American Medical Association Clears Path for Adenoviral Conjunctivitis Pink Eye Detector 5791 2Mesa Labs Reports Higher Quarterly Sales and Earnings 5787 1Mesa Labs Reports Higher Quarterly Sales and Earnings 5787 2Mesa Labs Reports Higher Quarterly Sales and Earnings 5787 3Mesa Labs Reports Higher Quarterly Sales and Earnings 5787 4Mesa Labs Reports Higher Quarterly Sales and Earnings 5787 5Heart Defects Can Delay Babys Brain Development 5783 1Heart Defects Can Delay Babys Brain Development 5783 2Heart Defects Can Delay Babys Brain Development 5783 3Heart Defects Can Delay Babys Brain Development 5783 4Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 1Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 2Dilon Technologies Explores Improvements in Molecular Breast Imaging 5779 3...e-FirstCall/ -- Quigley,Pharma, <a target="_blank"...Pharma.com , a wholly,owned subsidiary of The Quig...ted a follow-up study to evaluate the impact of QR...rleukin-6 (IL-6) in a,cachexia model. This new dat...of serum IL-6 when administered QR-443 orally than...
...7 --- Millipore Corporation today announced the re...em cell lines. The,research was conducted by the ...don and ReNeuron Group plc, whose ReNcell,distribu...6. ,The data will be presented by Dr. Vi Chu, rese...uo;s Bioprocess Division, in,a technology talk at ...
Other Medicine Technology:Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 2Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 3Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow - 4Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4